1. Khoja, Sheraz, Chen, Lulu Y. 2024. Conditional deletion of neurexin-2 impaired behavioral flexibility to alterations in action-outcome contingency. In Scientific reports, 14, 10187. doi:10.1038/s41598-024-60760-w. https://pubmed.ncbi.nlm.nih.gov/38702381/
2. Shen, Yufei, Tian, Yan, Ding, Jiashan, Li, Xi, Zhang, Yu. 2024. Unravelling the molecular landscape of endometrial cancer subtypes: insights from multiomics analysis. In International journal of surgery (London, England), 110, 5385-5395. doi:10.1097/JS9.0000000000001685. https://pubmed.ncbi.nlm.nih.gov/38775562/
3. Gerik-Celebi, Hamide Betul, Bolat, Hilmi, Unsel-Bolat, Gul. 2024. Rare heterozygous genetic variants of NRXN and NLGN gene families involved in synaptic function and their association with neurodevelopmental disorders. In Developmental neurobiology, 84, 158-168. doi:10.1002/dneu.22941. https://pubmed.ncbi.nlm.nih.gov/38739110/
4. Alves-Ferreira, Miguel, Quintas, Marlene, Sequeiros, Jorge, Neto, João Luís, Lemos, Carolina. 2021. A genetic interaction of NRXN2 with GABRE, SYT1 and CASK in migraine patients: a case-control study. In The journal of headache and pain, 22, 57. doi:10.1186/s10194-021-01266-y. https://pubmed.ncbi.nlm.nih.gov/34126933/
5. Ma, Cui, Zhang, Youyou. 2021. NRXN2 Possesses a Tumor Suppressor Potential via Inhibiting the Growth of Thyroid Cancer Cells. In Computational and mathematical methods in medicine, 2021, 7993622. doi:10.1155/2021/7993622. https://pubmed.ncbi.nlm.nih.gov/34777568/
智鼠故事 
